Therapeutic Effect of Microsclerotherapy in the Treatment of Facial Telangiectasia.
- Author:
Jee Bum LEE
1
;
Yong Pil NA
;
Seung Chul LEE
;
Young Ho WON
Author Information
1. Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea. jbmlee@chonnam.ac.kr
- Publication Type:Original Article
- Keywords:
Sclerotherapy;
Facial telangiectasia;
Sclerodex(R)
- MeSH:
Cicatrix;
Electrosurgery;
Follow-Up Studies;
Humans;
Recurrence;
Sclerotherapy;
Telangiectasis*
- From:Korean Journal of Dermatology
2002;40(6):616-619
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The treatment of facial telangiectasia include microsclerotherapy, laser, and electrosurgery. It is important that the treatment for telangiectasia be relatively risk-free, especially avoiding unsightly scarring. OBJECTIVE: We evaluated the effectiveness, complications, and recurrence rate of patients with facial telangiectasia treated with microsclerotherapy using osmotic sclerosing agent. In addition, we also evaluated the associated factors, the sites of predilection, and types of facial telangiectasia. PATIENTS AND METHODS: Fifteen patients with facial telangiectasia were treated with microsclerotherapy using osmotic sclerosant(Sclerodex(R)). The procedure was performed at 4 week intervals and on average 2 times. The effectiveness was evaluated by the comparison of photographs monthly during mean 6 months follow-up period. RESULTS: Mean improvement rate was 70% and partial recurrence was observed in 3 cases(20%). Transient bruising(33%), transient pigmentation(7%) and telangiectatic matting(7%) were observed as complications. CONCLUSION: Sclerotherapy with osmotic sclerosant(Sclerodex(R)) is safe and moderately effective; because it usually has more than a good response and minimal complications.
